Company News
Zig-Zag Owner Turning Point Brands Reports 133% Surge in Nicotine Pouch Sales
Turning Point Brands — the company behind the iconic Zig-Zag rolling papers — is rapidly reinventing itself as a nicotine-pouch powerhouse, and its latest financial results show just how fast that shift is happening. Fresh coverage on June 30, 2026, highlighted how the company's "Modern Oral" pouch segment has become its primary growth engine, a move that signals where the broader nicotine market is heading.
The Numbers Behind the Pivot
Turning Point Brands (TPB) reported first-quarter 2026 revenue of approximately $124.3 million, up roughly 17% year over year, according to industry reports. The standout performer was its Modern Oral segment — anchored by the FRE and ALP nicotine-pouch brands — where the growth was exponential:
- Net sales jumped about 133% year over year to roughly $52 million.
- Gross sales surged about 167% to around $69 million.
- The segment now accounts for roughly 42% of the company's net sales.
Confident in this momentum, TPB raised its full-year 2026 Modern Oral guidance to gross sales of $280–$300 million (up from previous estimates of $220–$240 million) and net sales of $210–$225 million. The company is aggressively investing in its salesforce and marketing to capture market share, expecting its pouch brands' chain-store presence to grow by roughly 70% by the end of the year.
Why the Industry is Shifting
This trend is playing out across the entire tobacco products industry: while combustible and traditional categories remain flat or in decline, nicotine pouches are growing at breakneck speed. A company best known for a 19th-century rolling-paper brand now derives nearly half of its business from pouches — a striking illustration of how consumer demand has shifted toward smoke-free formats.
"Combustible and traditional categories are flat-to-declining, while nicotine pouches are growing at breakneck speed."
This shift also connects to broader regulatory headlines. The pouch category recently saw its first modified-risk authorization for a competitor, and market data consistently shows smokeless products as the only growing nicotine segment. TPB's aggressive investment is a clear bet that the boom has significant room to run, much like how Swisher bets $135 million on its own oral nicotine expansion.
What This Means for Shoppers
For customers, corporate strategy may not change an immediate purchase, but it explains why the retail shelf is evolving. The rapid expansion of brands like FRE and ALP means more pouch options and wider availability. Increased competition among manufacturers can often lead to better selection and competitive pricing for the end consumer, similar to the variety found in the best cigarillos of 2026.
If you already use Zig-Zag rolling papers, these results serve as a reminder that the parent company is increasingly focused on the oral nicotine category. As Zig-Zag adapts to new trends, it continues to balance its heritage with modern consumer needs. However, it is important to note that booming sales are a market signal, not a health verdict. Nicotine pouches deliver addictive nicotine and are not approved as smoking-cessation aids.
The Bottom Line
Turning Point Brands' pivot is one of the clearest company-level signals yet that nicotine pouches are where the industry is investing. With pouch sales up triple digits and now representing nearly half of TPB's revenue, the "Modern Oral" category is no longer a side project—it is the future of the business. Even traditional leaders like Al Fakher are now entering the nicotine pouch market to keep pace with this demand.
For adults 21+. Nicotine is addictive, and nicotine pouches are not FDA-approved quit-smoking products. This article is general market information, not financial or medical advice.